| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |